Will COVID-19 confirmed cases in the USA reach 3 million? A forecasting approach by using SutteARIMA Method.

Curr Res Behav Sci

Department of Economic, Financial and Actuarial Mathematics, Faculty of Economics and Business, Universitat de Barcelona, Spain.

Published: November 2020

Objectives: Forecasting the number of COVID-19 cases in the USA can provide an overview and projection of the development of COVID-19 cases in the US so that policy makers can determine the steps that must be taken. This study aimed to determine whether COVID-19 confirmed cases in the USA would reach 3 million cases with the SutteARIMA method forecasting approach.

Methods: Data from this study were obtained from the Worldometer data on 15 February 2020 to 2 July 2020. Data from 15 February 2020 to 25 June 2020 were used to performance data fitting (26 June 2020-2 July 2020). Data fitting is used to examine the extent of the accuracy of the SutteARIMA method in predicting data. To examine the level of the data accuracy, the MAPE method was used in this study.

Results: The results of forecasting data fitting on 26 June 2020 - 2 July 2020: 2,544,732; 2,590,888; 2,632,477; 2,671,055; 2,711,798; 2,755,128; 2,803,729. The accuracy of SutteARIMA for the period of 26 June 2020-2 July 2020 based on MAPE was 0.539% and the forecasting results that had been obtained were 3 million confirmed cases, namely from 05 to 06 June 2020: 1,981,299; 2,005,706; 2,030,283; 2,055,031.

Conclusions: The SutteARIMA method predicted that 2 million confirmed cases of COVID-19 will be obtained on the WHO situation report on days 168-170 or 05-07 June 2020.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521377PMC
http://dx.doi.org/10.1016/j.crbeha.2020.100002DOI Listing

Publication Analysis

Top Keywords

confirmed cases
16
suttearima method
16
july 2020
16
june 2020
16
cases usa
12
data fitting
12
0
10
covid-19 confirmed
8
usa reach
8
covid-19 cases
8

Similar Publications

Background: Cardiac rhabdomyoma (RHM) is considered one of the most frequent benign heart tumors in children. However, encounters with cardiac RHM in clinical practice remain rare. Clinical information is primarily available in the form of single case reports or smaller studies with a shortage of large-scale reviews encompassing a substantial number of cases.

View Article and Find Full Text PDF

Background: Chronic Nonbacterial Osteomyelitis (CNO) is a rare auto-inflammatory disease that mainly affects children, and manifests with single or multiple painful bone lesions. Due to the lack of specific laboratory markers, CNO diagnosis is a matter of exclusion from different conditions, first and foremost bacterial osteomyelitis and malignancies. Whole Body Magnetic Resonance (WBMR) and bone biopsy are the gold standard for the diagnosis.

View Article and Find Full Text PDF

Clinical integration of germline findings from a tumor testing precision medicine program.

BMC Cancer

January 2025

Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.

Background: Integrating germline genetic testing (GGT) recommendations from tumor testing into hereditary cancer clinics and precision oncology trials presents challenges that require multidisciplinary expertise and infrastructure. While there have been advancements in standardizing molecular tumor boards, the implementation of tumor profiling for germline-focused assessments has only recently gained momentum. However, this progress remains inconsistent across institutions, largely owing to a lack of systematic approaches for managing these findings.

View Article and Find Full Text PDF

Background: Adverse birth outcomes are a significant public health problem worldwide, particularly in low- and middle-income countries. Adverse birth outcomes have significant immediate and long-term health consequences for infants and their families. Understanding the determinants of adverse birth outcomes is crucial to effective interventions.

View Article and Find Full Text PDF

Novel predictive biomarkers for atonic postpartum hemorrhage as explored by proteomics and metabolomics.

BMC Pregnancy Childbirth

January 2025

Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Peking University Third Hospital), National Center for Healthcare Quality Management in Obstetrics, Beijing, 100191, China.

Background: Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide, with uterine atony accounting for approximately 70% of PPH cases. However, there is currently no effective prediction method to promote early management of PPH. In this study, we aimed to screen for potential predictive biomarkers for atonic PPH using combined omics approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!